The Founder and CSO of EQUALY sa., Jean-Marie Saint-Remy, is sharing his ground-breaking discovery regarding the potential of the innate immune system to address various disorders. Founded in 2020, EQUALY sa. aims to develop a platform that harnesses this potential by activating natural killer T (NKT) cells specifically designed to recognize and respond to cancer-related antigens, such as those associated with TP53 mutations, which are present in over 60% of human cancers. Their innovative approach enables the creation of cost-effective, off-the-shelf therapies with minimal risk of off-target effects, making them adaptable for different patients with the same detected mutated transcription factor. Would like to learn more? Read the full story https://lnkd.in/eiauF6k5
Bioneex
科技、信息和网络
Syracuse,New York 3,526 位关注者
We connect drug development companies with strategic biopharma partners and venture capital investors
关于我们
Bioneex is the first AI-powered biopharma matchmaking platform. It connects early-stage drug development companies with strategic biopharma partners and venture capital investors to facilitate licensing, co-development partnerships and investments. Among our clients are some of the top biopharmaceutical companies and venture capital firms, such as Johnson & Johnson, Bayer, AbbVie, GlaxoSmithKline, BioNTech, Sofinnova Partners, Curie.Bio, Andera Life Sciences, Apple Tree Partners, TVM Capital Life Science, ALSA Ventures that are actively looking for drug candidates and technologies to in-license, co-develop and invest. Bioneex's vision is helping preclinical and clinical-stage drug development companies gain for their medicines in development vital exposure to the right partners and investors at the right time, which will increase the likelihood of moving these innovative drug candidates and technologies into the next stage of development and, ultimately to the patients as novel medicines.
- 网站
-
https://bioneex.com
Bioneex的外部链接
- 所属行业
- 科技、信息和网络
- 规模
- 11-50 人
- 总部
- Syracuse,New York
- 类型
- 私人持股
- 创立
- 2020
- 领域
- Biotech、Pharmaceuticals、Licensing、Online Platform、Biopharmaceutical、Biopharma、Pharma、Biopharma R&D、R&D Exchange Platform、Marketplace、Drug Candidates和Biopharma Assets
地点
Bioneex员工
-
Ben Williams
Company Creator & Investor in Life Sciences, AI, Decentralization Digital Health, and EdTech
-
Ray Jordan
-
Dan Zavodnick, JD
Empowering Biopharma with Legal, Compliance, and Ad Promo Excellence | President @ NorthStar Advisors
-
Erica Sosnowski
Driving Growth & Expediting Deals in Life Science Through Strategic Business Development | Managing Partner, Sosna + Co | Dealmaker & Partnership…
动态
-
Bioneex is thrilled to collaborate with GlycoMira Therapeutics, Inc. . GlycoMira Therapeutics, Inc. is pioneering a new class of innate immune system modulators to transform cancer treatment. Their lead candidate, GM-1111, is a first-in-class multi-modal immune modulator with potent anti-tumor, anti-inflammatory, and radioprotective properties. Looking for groundbreaking therapies? Let's connect through Bioneex (https://bioneex.com/) and explore partnership opportunities!
-
-
Heegon Kim, the CEO of Renatus is sharing their mission to revolutionize cholesterol modulation with safer and more effective cyclodextrin-based therapies. Their lead candidate, RN-005, features cross-linked cyclodextrins, which are engineered to overcome the safety challenges of traditional cyclodextrins, such as the ototoxicity or “ear poisoning”, while maintaining high efficacy. Shifting their mechanism of action, Renatus' pipeline spans a range of cholesterol-driven diseases including Diabetic kidney diseases, Alzheimer’s, Niemann-Pick Type C or Atherosclerosis among others. Renatus is committed to improving the patient outcomes through its innovative approaches to cholesterol metabolism, making significant strides in tackling cholesterol-driven diseases.
-
Secure CDAs & Data Rooms on Bioneex! ?? A new feature is coming soon. Confidentiality and secure data sharing are critical in biopharma dealmaking. That’s why Bioneex is launching a new CDA & Data Room feature enabling companies to effortlessly sign CDAs and exchange sensitive documents in a controlled, encrypted environment. ? Instant CDA Execution – Secure, legally binding agreements within minutes ? Confidential Data Sharing – Exchange key documents with full control ? Streamlined Collaboration – Speed up deal negotiations With this feature, Bioneex strengthens its position as the trusted matchmaking platform for biopharma dealmaking.
-
-
?? At Bioneex (https://lnkd.in/eyUPKfsc) we connect drug development companies with strategic partners and venture capital investors. We combine the power of AI with the expertise of our scientific team to do customised matchmaking tailored to your needs. Once we find a perfect match, your dedicated scientific manager sends an introductory message to both parties. Then you can take the lead and continue the conversation. Bioneex is a well-structured platform that enables you to run your conversation with potential partners and investors smoothly while also securely sharing confidential information.
-
-
Bioneex转发了
Bioneex connects biotech companies (Providers) and biopharma & VC partners (Seekers) looking to collaborate and scale innovation: As a Seeker on Bioneex, you can: ?? Create company profile ??Search Unlimitedly drug candidates with AI Assistant ??Receive messages ??Do Trial matchmaking Want to benefit more? Become a Seeker Member to: ??Access reviewed drug candidates' detailed information ??Contact Providers ??Receive matchmaking facilitation based on your preferences ??Deal flow automation and updates on your watchlist We believe in innovation, join us at Bioneex (https://lnkd.in/eyUPKfsc) and let the collaboration begin.
-
-
At Bioneex we provide a complete and refined data package for each drug candidate asset, which includes: ? Careful review non-confidential information ? Regular updates and improvement suggestions from our scientific team ? Ongoing refinements based on your feedback for optimal matchmaking This ensures you always have the most comprehensive insights with Bioneex ( https://lnkd.in/eyUPKfsc ) to make informed decisions.
-